REG - RUA Life Sciences - Posting of Annual Report and Notice of AGM

Rua Life SciencesAnnouncement

12/02/2026 13:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260212:nRSL8199Sa&default-theme=true

RNS Number : 8199S  RUA Life Sciences PLC  12 February 2026

12 February 2026

 

RUA Life Sciences Plc

("RUA Life Sciences", the "Company" or the "Group")

Posting of Annual Report and Accounts and Notice of Annual General Meeting

RUA Life Sciences (AIM: RUA), the holding company of a group of medical device
businesses focused on the exploitation of the world's leading long-term
implantable biostable polymer (Elast-Eon™), announces that the Company's
Annual Report & Accounts, along with the Company's Notice of Annual
General Meeting ("AGM") has been posted to shareholders and is available on
the Company's website: www.rualifesciences.com/investor-relations
(http://www.rualifesciences.com/investor-relations) .

The AGM will be held at 11.00 am on 17 March 2026 at Gailes Hotel, Marine
Drive, Irvine, Ayrshire KA11 5AE.

 

 

For further information contact:

 

   RUA Life Sciences

 Bill Brown, Chairman                                                  Tel: +44 (0)1294 317073

 Lachlan Smith, CFO                                                    Tel: +44 (0)1294 317073

 Cavendish Capital Markets                                             Tel: +44 (0)20 7220 0500
 Limited

 (Nominated Adviser and Broker)

 Giles Balleny/Isaac Hooper (Corporate Finance)

 Harriet Ward (Broking)

 Nigel Birks (Healthcare Specialist Sales)

 Michael Johnson (Sales)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSTTMJTMTJBBTF



            Copyright 2019 Regulatory News Service, all rights reserved